News O'Shaughnessy says UK clinical trials sector is on the mend After losing ground in commercial clinical trials in recent years, the UK has now turned a corner and is once again taking a "global lead."
News Organised medicines trafficking, 12 arrests made in MHRA cra... In dawn raids, 12 suspects were arrested in the largest criminal investigation into organised medicines trafficking in the history of the MHRA.
News GSK cements Blenrep comeback with MHRA approval GSK's Blenrep has nearly completed its winding road as the multiple myeloma drug receives approval for second-line us in the UK.
News Lawrence Tallon will lead MHRA after June Raine retires Lawrence Tallon has been named head of the MHRA, effective 1st April, replacing Dame June Raine who is retiring.
Market Access The Windsor Framework: Insights on the regulatory shift for ... The Windsor Framework marks a significant change in the UK's post-Brexit regulatory space, particularly for the pharmaceutical sector
Market Access Looking ahead in 2025 and MHRA reliance International reliance is a mechanism whereby certain medical devices could access the UK market more quickly if they have already been approved by a comparable regulator, rather than under
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face